News for 'US Patent Office'

Patent Office upholds Natco's plea

Patent Office upholds Natco's plea

Rediff.com16 Mar 2009

Drug maker Natco on Monday said that the Patent Office has upheld the firm's opposition to an application of Yeda Research & Development Company for patenting a generic version of a product of Teva Pharmaceutical Industries.

Indian Patent Office rejects Google's invention

Indian Patent Office rejects Google's invention

Rediff.com14 Jun 2017

The application was filed in 2006 by Motorola Mobility LLC, now changed to Google Technology Holdings LLC for method and apparatus of providing text messages

Patent offices come under lens

Patent offices come under lens

Rediff.com9 Jun 2008

The medicines include tuberculosis drug moxifloxacin, antipsychotic olanzapine and valgancicloivir, a medicine often needed for HIV/AIDS patients. The groups allege that none of these drugs qualified the criteria specified under the Indian Patents Act and were given patent protection because the patent examiners overlooked the legal safeguards meant to avoid grant of patents to known substances or their mere improvements.

Patent office sees surge in online applications

Patent office sees surge in online applications

Rediff.com1 Aug 2008

In less than a year since the first patent electronic application was filed at the Indian Patent Office, the number has increased to 1,000, up three per cent.

Public Cloud Service Drives Oracle India's Double-Digit Run

Public Cloud Service Drives Oracle India's Double-Digit Run

Rediff.com18 Feb 2026

'India is often skipping legacy cycles and moving directly to advanced AI-driven operations.'

'The Key Is Talent, Technology, Trust'

'The Key Is Talent, Technology, Trust'

Rediff.com30 Dec 2025

'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'

National Herald case: HC to hear ED plea against Gandhis on Mar 9

National Herald case: HC to hear ED plea against Gandhis on Mar 9

Rediff.com19 Feb 2026

The Delhi High Court has scheduled a hearing for March 9 on the Enforcement Directorate's plea challenging a trial court order that refused to acknowledge its chargesheet against Congress leaders Sonia and Rahul Gandhi in the National Herald money laundering case.

Patent office to hire 500 this year

Patent office to hire 500 this year

Rediff.com26 Apr 2010

Sources said the people would be hired at different levels, including application examiners.

Patent office rejects Roche claim on eye drug

Patent office rejects Roche claim on eye drug

Rediff.com6 May 2010

Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

'GCCs Have Evolved To Strategic Innovation Hubs'

'GCCs Have Evolved To Strategic Innovation Hubs'

Rediff.com6 Jan 2026

'Solutions developed in India are being commercialised and offered globally because we're executing at scale, creating new markets and revenue streams.'

Tata Motors files record patent applications in FY25

Tata Motors files record patent applications in FY25

Rediff.com17 Apr 2025

Tata Motors on Thursday said it has filed 250 patents and 148 design applications, its highest-ever in a single year, in FY25. The filings encompass a broad spectrum of product and process innovations, aligning with key automotive megatrends such as Connectivity, Electrification, Sustainability, and Safety (CESS), as well as emerging technologies like hydrogen-based vehicles and fuel cells, the Mumbai-based auto major said in a statement.

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

Rediff.com25 Jun 2024

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.

Legal Tussles Rock India's IT Sector

Legal Tussles Rock India's IT Sector

Rediff.com14 Oct 2025

2025 has seen a sharp rise in lawsuits targeting IT services and consulting companies, which now increasingly offer proprietary digital platforms and cloud services.

'Bulldozer Justice Continues Despite SC Verdict'

'Bulldozer Justice Continues Despite SC Verdict'

Rediff.com2 Dec 2025

'Even as the Supreme Court's anti-punitive demolition judgment nears its first anniversary, no formal contempt proceedings have been initiated either by the Supreme Court or any high court against officers or demolition squads who have acted in violation of it.'

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

India granted over 1 lakh patents in FY24

India granted over 1 lakh patents in FY24

Rediff.com25 Apr 2024

India granted 1.03 lakh patents in financial year 2023-24, Controller General of Patents, Designs and Trademarks Unnat Pandit said on Thursday, as he assured that there will be "no delay" in the Intellectual Property Office as it prioritises timely clearance of applications. Addressing an Assocham event here, he shared that 40 per cent of the applications were disposed of within 30 months of the request for examination. "We are going to have no delay in the IP office, that's the motive with which we have .. that IP should be granted and under Chapter 8 of the Act it should also be utilised by the applicant ... that will generate the economic value of IP," Pandit said.

Trump announces 100% tariffs on foreign-made movies, India to be hit

Trump announces 100% tariffs on foreign-made movies, India to be hit

Rediff.com30 Sep 2025

Trump said California has been particularly "hard hit" because of this, blaming democrat Gavin Newsom, the Governor of California, for this loss, calling him "weak and incompetent."

Agnikul Launches India's 1st 3D-Printed Rocket Hub

Agnikul Launches India's 1st 3D-Printed Rocket Hub

Rediff.com23 Sep 2025

For the first time in India, the facility enables 3D printing of aerospace and rocket components up to one metre in height.

When Will Vijay Smell The Coffee?

When Will Vijay Smell The Coffee?

Rediff.com10 Nov 2025

TVK cadres are worried, the leadership looks weak, and the party is not fully prepared for the 2026 elections, observes N Sathiya Moorthy.

FIR against Malviya, Arnab Goswami for 'Cong office in Turkiye' claim

FIR against Malviya, Arnab Goswami for 'Cong office in Turkiye' claim

Rediff.com21 May 2025

An first information report (FIR) was registered on Tuesday against Bharatiya Janata Party IT cell head Amit Malviya and Editor-in-Chief of Republic TV, Arnab Goswami for allegedly running false information, police said.

EV Spark Fires Up R&D Spending By Legacy Two-Wheeler Majors

EV Spark Fires Up R&D Spending By Legacy Two-Wheeler Majors

Rediff.com3 Sep 2025

Hero MotoCorp and TVS Motor crossed Rs 1,000 crore in R&D spend for the first time, as legacy OEMs accelerate innovation to compete with new-age EV players.

US again puts India on 'priority watch list' for alleged IP rights' violations

US again puts India on 'priority watch list' for alleged IP rights' violations

Rediff.com29 Apr 2025

The US on Tuesday again placed India on its 'priority watch list' stating that New Delhi remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP) rights.

'Inadvertent': Reliance withdraws Op Sindoor trademark application

'Inadvertent': Reliance withdraws Op Sindoor trademark application

Rediff.com8 May 2025

Reliance Industries Ltd has withdrawn its trademark application for the term 'Operation Sindoor' -- the codename for India's military strikes in Pakistan -- stating that it was inadvertently filed by a junior employee without authorisation.

India rejects Google's patent plea for e-shoe

India rejects Google's patent plea for e-shoe

Rediff.com29 Feb 2020

The patent application for 'System and method for wearable electronic devices', filed in 2007, mentions various wearable models including a shoe that can communicate data to the user, electronic communication devices attached to clothes, wireless ear pieces and ankle bracelets that can transmit updated information from the body to the user. The drawings the company submitted to the patent office also show the design of a shoe that can be a wearable electronic device.

Accept Aadhaar, voter ID: SC to poll panel on Bihar SIR

Accept Aadhaar, voter ID: SC to poll panel on Bihar SIR

Rediff.com28 Jul 2025

Underscoring the 'presumption of genuineness' of Aadhaar and voter ID, the Supreme Court on Monday refused to stay the publication of draft electoral rolls in poll-bound Bihar and said it would once and for all decide pleas against Election Commission's special intensive revision (SIR) of electoral rolls.

Rush begins to become patent agents

Rush begins to become patent agents

Rediff.com11 Jan 2010

There has been a sharp increase in the number of graduates who want to qualify as patent agents -- the intermediates between patent applicants and the patent office. Over 2,000 persons will appear for the national level examination conducted by the patent office that qualifies graduates to work as patent agents later this month. This is a five-fold increase over the number of applications that had reached the patent office last year.

SC to hear pleas against EC's Bihar voter list overhaul on Monday

SC to hear pleas against EC's Bihar voter list overhaul on Monday

Rediff.com27 Jul 2025

A bench of Justices Surya Kant and Joymalya Bagchi is likely to take up the matter in which the EC has justified its ongoing SIR of electoral rolls in Bihar, saying it adds to the purity of the election by "weeding out ineligible persons" from the electoral rolls.

When Gujarati Muslims Dominated Bombay Politics

When Gujarati Muslims Dominated Bombay Politics

Rediff.com26 Aug 2025

'They wanted the city to be a great business hub. They didn't like the fact that taxes collected in Bombay would go outside the city.'

'One Can't Monopolise Captain Cool'

'One Can't Monopolise Captain Cool'

Rediff.com18 Jul 2025

If the 'Captain Cool' trademark goes through, it could trigger a wave of similar attempts by celebrities to trademark nicknames given to them by fans.

SC bats for 'one rank one pension' for all ex-HC judges

SC bats for 'one rank one pension' for all ex-HC judges

Rediff.com19 May 2025

The Supreme Court on Monday directed uniform pension benefits for all retired high court judges, irrespective of their mode of appointment or tenure, saying "one rank one pension has to be the norm in respect of a constitutional office".

Roche's Hepatitis C drug patent challenged

Roche's Hepatitis C drug patent challenged

Rediff.com12 Jun 2007

Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office.

India rejects patent to Glivec's second variant

India rejects patent to Glivec's second variant

Rediff.com15 Apr 2009

In yet another setback to Swiss drug multinational Novartis AG, the Indian patent office has rejected its application to secure a patent for an alfa crystal form of its blockbuster cancer medicine, Glivec.

Tackling software patents innovatively

Tackling software patents innovatively

Rediff.com3 Jul 2008

The contentious issue of software patents is rearing its head again, both in India and globally. The Indian Patent Office, for instance, invited companies and institutions to comment on its Draft Manual 2008 - Patent Practice & Procedure (software patents included) this April.

CAT overturns transfer of Sameer Wankhede

CAT overturns transfer of Sameer Wankhede

Rediff.com6 Mar 2025

The Central Administrative Tribunal (CAT) has overturned the transfer of Indian Revenue Service (IRS) officer Sameer Wankhede from Mumbai to Chennai, ruling that the revenue department violated its own guidelines. Wankhede, known for his role in the Cordelia cruise drug bust case involving Bollywood actor Shah Rukh Khan's son, had claimed his transfer was punitive and a consequence of his actions at the Narcotics Control Bureau (NCB). The CAT found procedural lapses and potential bias in the transfer decision, stating that transfer policies must be implemented fairly and transparently.

US co's AIDS drug: India refuses patent protection

US co's AIDS drug: India refuses patent protection

Rediff.com2 Sep 2009

In a victory for Indian drug companies, patent protection has been refused to Tenofovir, an anti-AIDS medicine of the US-based Gilead Sciences. The decision was taken by the patent office in New Delhi.

Pharma tops in patent suits

Pharma tops in patent suits

Rediff.com18 Jan 2010

Pharmaceutical patents are just over a fourth of all patents granted in the country, but domestic drug makers account for almost all post-grant patent opposition filed, official data reveals.

Army takes out patent on new camouflage-style uniform

Army takes out patent on new camouflage-style uniform

Rediff.com3 Nov 2022

The Indian Army on Thursday said it has registered the intellectual property rights of its new design and camouflage pattern uniform.

India partly revokes Roche cancer drug patent

India partly revokes Roche cancer drug patent

Rediff.com5 Aug 2013

Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com5 Jun 2025

'We recently launched Yesintek in the immunology space.'